StockNews.com lowered shares of USANA Health Sciences (NYSE:USNA – Free Report) from a strong-buy rating to a buy rating in a research report sent to investors on Friday morning.
Separately, DA Davidson increased their target price on USANA Health Sciences from $35.00 to $38.00 and gave the company a “neutral” rating in a research note on Thursday, January 2nd.
Check Out Our Latest Research Report on USNA
USANA Health Sciences Stock Up 0.4 %
Hedge Funds Weigh In On USANA Health Sciences
Hedge funds and other institutional investors have recently modified their holdings of the company. R Squared Ltd bought a new position in shares of USANA Health Sciences during the 4th quarter valued at $28,000. Safe Harbor Fiduciary LLC purchased a new position in USANA Health Sciences during the third quarter valued at $30,000. KBC Group NV lifted its position in USANA Health Sciences by 96.6% during the third quarter. KBC Group NV now owns 1,056 shares of the company’s stock valued at $40,000 after purchasing an additional 519 shares in the last quarter. KLP Kapitalforvaltning AS purchased a new position in shares of USANA Health Sciences in the fourth quarter valued at about $83,000. Finally, Quantbot Technologies LP purchased a new position in shares of USANA Health Sciences in the fourth quarter valued at about $132,000. 54.25% of the stock is owned by institutional investors.
About USANA Health Sciences
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
See Also
- Five stocks we like better than USANA Health Sciences
- How to Buy Cheap Stocks Step by Step
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- What is the Hang Seng index?
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- The Most Important Warren Buffett Stock for Investors: His Own
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.